SAGA is a precision cancer diagnostics company featuring ultrasensitive monitoring of circulating tumor DNA — a game-changer to improve patient outcomes.
Location: Sweden, Scania, Lund
Employees: 11-50
Phone: +46 73 301 72 42
Total raised: $16.58M
Founded date: 2016
Investors 2
| Date | Name | Website |
| 07.12.2023 | Rose Ventu... | roseventur... |
| - | Hadean Ven... | hadeanvent... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 30.06.2021 | - | $12.48M | Hadean Ven... |
| 13.06.2019 | - | $4.1M | - |
Mentions in press and media 12
| Date | Title | Description |
| 15.09.2026 | The Scientist Announces the 2026 Top Innovations Winners | Ten groundbreaking technologies are recognized across biotechnology, healthcare, lab tools, and startup innovations. WILMINGTON, Del., Sept. 15, 2026 /PRNewswire-PRWeb/ -- The Scientist proudly unveils the winners of this year's Top Innovat... |
| 12.04.2023 | Startup Showcase: SAGA Diagnostics – Revolutionizing Cancer Diagnostics and Monitoring | SAGA Diagnostics AB is a personalized cancer diagnostics and disease monitoring company focused on molecular genetic analyses of a powerful cancer biomarker: circulating tumor DNA (ctDNA). The company was founded in 2016 as a spin-out from ... |
| 02.11.2021 | SAGA Diagnostics enters into an assay development agreement with AstraZeneca | SAGA Diagnostics enters into an assay development agreement with AstraZeneca Tue, Nov 02, 2021 12:00 CET LUND, Sweden — /November 2, 2021/ — SAGA Diagnostics AB, a cancer liquid biopsy and genomic testing company focused on precision oncolo... |
| 07.10.2021 | SAGA Diagnostics appoints Peter Collins as Chief Executive Officer | SAGA Diagnostics appoints Peter Collins as Chief Executive Officer Thu, Oct 07, 2021 08:41 CET LUND, Sweden - /October 7, 2021/ – SAGA Diagnostics AB (“SAGA”), a leading cancer liquid biopsy and genomic testing company, is pleased to announ... |
| 29.06.2021 | SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasensitive cancer liquid biopsies | |
| 29.06.2021 | SAGA Diagnostics raises €10.5 million | SAGA Diagnostics raises SEK 106 million (€10.5 million) to accelerate commercialization of ultrasensitive cancer liquid biopsies SAGA Diagnostics AB (“SAGA”), a cancer liquid biopsy and genomic testing company, today announced that it has ... |
| 25.03.2021 | French biotech company Step Pharma raises €35 million in Series B | Step Pharma, a Paris based biotech company, announced on 24th March 2021 that it has raised €35 million in its Series B funding round. The round was led by Sunstone Life Science Ventures and Hadean Ventures, along with participation from Ku... |
| 17.06.2019 | The Hot IPO You Might Have Overlooked: Term Sheet | CONSUMERIZE THE ENTERPRISE While we all gave our undivided attention to flashy IPOs like Uber and Lyft, many overlooked the public market debut of cloud-based cybersecurity company CrowdStrike. You’ve probably heard of it without realizing ... |
| 13.06.2019 | Saga Diagnostics raises $4.1M for its ultrasensitive cancer blood tests | Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive liquid biopsy tests for the monitoring of cancer treatments. A spinout from Lund University in Sweden, Saga aims to quantify ab... |
| 13.06.2019 | Saga Diagnostics raises $4.1M for its ultrasensitive cancer blood tests | Saga Diagnostics has raised 40 million Swedish kronor, or about $4.1 million, to help develop its ultrasensitive liquid biopsy tests for the monitoring of cancer treatments. Sponsored by Agilent Technologies How would you like to win free b... |
Show more